|
|
 |
|
Viewing report
|
|
|
|
The Lifestyle Drugs Outlook To 2008: Unlocking New Value In Well-Being
Business Insights, Oct 2003, Pages: 246
The lifestyle drugs market is currently worth a phenomenal $23bn to boost its value, pharmaceutical companies are actively searching for new lifestyle products and conditions. The Lifestyle Drugs Outlook to 2008: Unlocking new value in well-being, provides a timely market update, examining leading products and pipeline prospects in seven key lifestyle drug sectors, and is supported by forecasts to 2008. Today's R&D is influenced as much by commercial unmet needs as it is by clinical opportunities and chance. Pharmaceutical companies must react quickly to these needs if they are to reap greater financial returns. This report can help you to assess the premium associated with different lifestyle drug markets and identify the potential for higher volume sales. Armed with this information your company can formulate winning lifestyle drug development and marketing strategies, and secure a strong competitive position within this market.
Customers who bought this item also bought
Lifestyle Drugs Market Outlook: Key Indications, Epidemiology, and Emergent Drugs
Antiageing and Life Enhancement Pharmacotherapeutics: Rejuvenating Drug Markets To 2012 and Beyond
The Lifestyle Disorders Market Outlook to 2014: Reimbursement Issues, Market Dynamics, Pipeline Compounds
Transdermal Drug Delivery - Technologies, Markets, and Companies
Stakeholder Opinions: Sexual Dysfunction - The Quest for the New Viagra Continues
The Lifestyle Drugs Outlook To 2007: Challenges And Opportunities In A High-Profile Growth Market
European Lifestyle Disorders Therapeutics Market
The World Market For Sexual Disorders, 2005-2012: Traversing New Frontiers in Sexual Chemistry
Contraceptives - Global Strategic Business Report
Nitric Oxide - Therapeutics, Markets and Companies
Commercial Opportunities From An Aging Population: Epidemiology, Market And Pipeline Analysis Across Seven Major Indications
Transdermal & Transmucosal Delivery of Therapeutics, 2nd Edition
|
|
|
|
